Design and Rationale of MYOFLAME-19 RCT: MYOcardial protection to reduce inFLAMmatory heart disease due to COVID-19 Infection using CMR Endpoints.
Puntmann VO, Beitzke D, Kammerlander A, Voges I, Gabbert DD, Doerr M, Chamling B, Bozkurt B, Kaski JC, Spatz E, Herrmann E, Rohde G, DeLeuw P, Taylor L, Windemuth-Kieselbach C, Harz C, Santiuste M, Schoeckel L, Hirayama J, Taylor PC, Berry C, Nagel E.
Puntmann VO, et al. Among authors: herrmann e.
J Cardiovasc Magn Reson. 2024 Oct 29:101121. doi: 10.1016/j.jocmr.2024.101121. Online ahead of print.
J Cardiovasc Magn Reson. 2024.
PMID: 39481808
Free article.